Cargando…
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
BACKGROUND: Doxorubicin is considered one of the most potent established chemotherapeutics in the treatment of liposarcoma; however, the response rates usually below 30%, are still disappointing. This study was performed to identify gene expression changes in liposarcoma after doxorubicin treatment....
Autores principales: | Adrien, Daigeler, Ludger, Klein-Hitpass, Michael, Chromik Ansgar, Oliver, Müller, Jörg, Hauser, Heinz-Herbert, Homann, Hans-Ulrich, Steinau, Marcus, Lehnhardt |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585096/ https://www.ncbi.nlm.nih.gov/pubmed/18959781 http://dx.doi.org/10.1186/1471-2407-8-313 |
Ejemplares similares
-
Malignant fibrous histiocytoma—pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study
por: Daigeler, Adrien, et al.
Publicado: (2009) -
Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways
por: Lehnhardt, Marcus, et al.
Publicado: (2005) -
TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma
por: Daigeler, Adrien, et al.
Publicado: (2008) -
Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells
por: HARATI, KAMRAN, et al.
Publicado: (2016) -
Merkel cell carcinoma metastasis and dermatofibrosarcoma protuberans presenting as a collision tumour: a case report and review of the literature
por: Tilkorn, Daniel-Johannes, et al.
Publicado: (2009)